The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population
- 1 September 2004
- journal article
- Published by Wiley in Addiction Biology
- Vol. 9 (3-4) , 221-226
- https://doi.org/10.1111/j.1369-1600.2004.tb00536.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The dopamine D2 receptor (DRD2) gene–a genetic risk factor in heavy smoking?Addiction Biology, 2000
- Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteersMolecular Psychiatry, 1999
- D2 dopamine receptor gene (DRD2) Taql A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allelePharmacogenetics, 1997
- Genetic and environmental contributions to smokingAddiction, 1997
- Predictors of smoking cessation in a cohort of adult smokers followed for five yearsTobacco Control, 1997
- The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smokingPharmacogenetics, 1996
- Comprehensive, serologically equivalent DNA typing for HLA‐B by PCR using sequence‐specific primers (PCR‐SSP)Tissue Antigens, 1995
- The sobering D2 storyScience, 1994
- D2 dopamine receptor gene and cigarette smoking: A reward gene?Medical Hypotheses, 1994
- Substance abuse vulnerability and D2 receptor genesTrends in Neurosciences, 1993